Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Video content material above is prompted by the next questions:Please present an summary of the AGAVE-201 trial, together with its design, affected person...
Day One Biopharmaceuticals mentioned Tuesday the Meals and Drug Administration gave accelerated approval to its focused tablet for one of the frequent types...
This picture offered by the Pennsylvania Lottery exhibits Donna Osborne, 75, left, posing for a photograph with PA Lottery Deputy Director of Company...
